| Financial Year |
March 31 2023 |
| Monetary Funds |
1,004,248,517.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,325,097.97 |
| Accounts Receivable |
5,821,701.48 |
| Advances to Suppliers |
12,505,512.71 |
| Other Receivables |
477,602.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
193,303,771.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,931,001.23 |
| Total Current Assets |
1,250,930,402.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
184,698,908.92 |
| Investment Properties |
246,457,710.02 |
| Fixed Assetes |
116,040,443.51 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,578,835.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
23,684,705.61 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,137,289,533.33 |
| Total Assets |
2,388,219,935.89 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
46,540,361.88 |
| Accounts Received In Advance |
248,039.44 |
| Employee Compensation Payable |
636,659.95 |
| Taxes Payable |
57,619,552.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,435,342.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
660,070.16 |
| Other Current Liabilities |
11,379,371.29 |
| Sub-Total of Current Liabilities |
222,295,997.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,920,624.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,099,818.85 |
| Total Liabilities |
254,395,816.61 |
| Paid-In Capital(Or Share Stock) |
519,458,538.00 |
| Capital Surplus |
1,535,583,090.60 |
| Surplus Reserve |
520,744,106.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-397,781,404.28 |
| Minority Stockholder's Interest |
-133,942,084.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,267,766,203.53 |
| Owner's Equity（Stockholder's Equity） |
2,133,824,119.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,388,219,935.89 |
